Considerable evidence has accumulated to support hypothesis of Burn and Rand (1) that tyramine acts by releasing catecholamine from the tissue stores (2-5). Vane (6) observed that tyramine pro duced a stimulant effect on rabbit duodenum and a biphasic effect on rat stomach strip. This effect was inhibited by bromlysergic acid diethylamide (BOL) and phenoxybenzamine.
Experiments were performed on isolated uteri obtained from rats pretreated with diethyl stilbo esterol (10 og/100 g) for two days. Some of these rats were also pretreated with reserpine (15 mg/100 g) for two days. The uteri were suspended in 10 ml bath containing aerated de Jalon's fluid. The contractions were recorded on the smoked kymograph paper with the help of a lever having frontal writing point. The drugs used were tyramine hydrochloride and 5-hydroxytryptamine creatinine sulphate.
Tyramine did not produce any effect on rat uterus in concentrations ranging from 1 Eeg/ml to 1000 pg/ml. The effect of tyramine was also studied on uteri obtained from reserpinised rats to rule out the possibility of released catecholamines having masked the stimulant action of tyramine. How ever, in this series of experiments also tyramine failed to produce a contraction. In both the series the uteri were sensitive to concentrations of 5-HT as low as 0.025 pg/ml. Considering the work of
Vane (6) It thus appears that tyramine does not act on tryptamine receptors and that the results obtained by Vane (6) can be explained on the basis that tyramine releases acetylcholine (11).
It could be argued that tyramine should have contracted the rat uterus if it releases acetylcho line. The failure of tyramine to cause the contraction may be due to a minimal content of acetyl choline in the uterine tissue -a fact supported by the observation that physostigmine also fails to stimulate the uterus (12). Thus it appears that tyramine produces acetylcholine-like effects only in tissues rich in acetylcholine e.g. brain (10) and rabbit atrium and ileum (11).
